Biogen

+$1.98 (+0.97%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.

About BIIB

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis.

CEO
Michel Vounatsos
Employees
9,610
Headquarters
Cambridge, Massachusetts
Founded
1978

BIIB Key Statistics

Market cap
30.20B
Price-Earnings ratio
21.13
Dividend yield
—
Average volume
927.80K
High today
$207.36
Low today
$203.13
Open price
$205.26
Volume
1.01M
52 Week high
$468.55
52 Week low
$187.16

BIIB News

Simply Wall StMay 24

How Much Of Biogen Inc. Do Institutions Own? - Simply Wall St

If you want to know who really controls Biogen Inc. ( ), then you'll have to look at the makeup of its share registry. Institutions will often hold stock in big
Barron'sMay 24

Who Will Lead Biogen? Some Likely CEO Picks From Analyst. - Barron's

Biogen set off a high-stakes guessing game early this month when it announced that its CEO Michel Vounatsos would leave, after the company effectively threw in
Barron'sMay 24

Who Will Lead Biogen? This Analyst Offers Some Likely Picks.

Text size Biogen set off a high-stakes guessing game early this month when it announced that its CEO Michel Vounatsos would leave, after the company effectivel

BIIB Earnings

$0.00
$2.95
$5.89
$8.84
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, Pre-Market

More BIIB News

BenzingaMay 23

Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm

The commercial failure of Biogen Inc's BIIB drug Aduhelm has put a new focus on the research into the causes of Alzheimer's disease. Aduhelm was expected as a
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure